Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)
China flag China · Delayed Price · Currency is CNY
23.04
-1.18 (-4.87%)
At close: Sep 4, 2026

SHA:688806 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-510.6-601.38-514.77-446.46-428.67
Depreciation & Amortization
40.2339.7936.9934.0826.7
Other Amortization
14.8823.7730.9430.3122.82
Loss (Gain) From Sale of Assets
0.430.220.6110.80.13
Asset Writedown & Restructuring Costs
13.112.791.580.4618.87
Loss (Gain) From Sale of Investments
-11.35-11.35-4.57-8.926.92
Stock-Based Compensation
53.0153.0151.3954.4-
Provision & Write-off of Bad Debts
2.264.320.03-0.280.13
Other Operating Activities
15.8410.634.034.2317.94
Change in Accounts Receivable
-37.07-95.593.8113.69-3.07
Change in Inventory
-50.41-50.41-34.03-2.36-0.76
Change in Accounts Payable
15.0534.1954.710.93-17.91
Change in Other Net Operating Assets
19.39---34.43
Operating Cash Flow
-445.99-580.01-369.29-309.09-302.49
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-63.22-22.35-16.26-20.86-60.35
Sale of Property, Plant & Equipment
0.05-00.61-
Investment in Securities
1.16-5.6427.08-30-
Other Investing Activities
2.513.357.449.417.59
Investing Cash Flow
-59.5-24.6518.25-40.84-52.76

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Issued
-448.33263.26142.38106.22
Long-Term Debt Repaid
--144.75-62.41-81.22-110.67
Net Debt Issued (Repaid)
265.69303.58200.8561.16-4.45
Issuance of Common Stock
37.98310.98139.96146.83452.37
Common Dividends Paid
-19.7-17.2-8.57-3.62-4.53
Other Financing Activities
118.83-35.39-3.91-32.38-11.57
Financing Cash Flow
402.8561.98328.33171.99431.82

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
-5.34-1.360.960.754.08
Miscellaneous Cash Flow Adjustments
00-0--
Net Cash Flow
-108.03-44.04-21.74-177.1980.65

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-509.21-602.36-385.55-329.96-362.84
Free Cash Flow Growth
-----
Free Cash Flow Margin
-435.49%-1175.92%-2560.78%--8360.75%
Free Cash Flow Per Share
-1.31-1.56-1.06-1.05-2.27
Levered Free Cash Flow
--422.4-198.23-158.53-
Unlevered Free Cash Flow
--411.15-190.59-154.62-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Income Tax Paid
2.732.730.2-23.72-18.22
Change in Working Capital
-53.04-111.8124.4912.2612.69